Kirzinger, L., & Marx, A. (2016). Octreotide LAR and prednisone as neoadjuvant treatment in patients with primary or locally recurrent unresectable thymic tumors: A phase II study. PLOS ONE, 11(12), . https://doi.org/10.1371/journal.pone.0168215
Chicago-Zitierstil (17. Ausg.)Kirzinger, Lukas, und Alexander Marx. "Octreotide LAR and Prednisone as Neoadjuvant Treatment in Patients with Primary or Locally Recurrent Unresectable Thymic Tumors: A Phase II Study." PLOS ONE 11, no. 12 (2016). https://doi.org/10.1371/journal.pone.0168215.
MLA-Zitierstil (9. Ausg.)Kirzinger, Lukas, und Alexander Marx. "Octreotide LAR and Prednisone as Neoadjuvant Treatment in Patients with Primary or Locally Recurrent Unresectable Thymic Tumors: A Phase II Study." PLOS ONE, vol. 11, no. 12, 2016, https://doi.org/10.1371/journal.pone.0168215.